Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination (Q121634)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination |
scientific article |
Statements
17
0 references
6
0 references
734-749
0 references
15 August 2018
0 references
